Finally, the expression and function of CLCN3 were regulated by HNRNPK in vitro and in vivo, and the HNRNPK-CLCN3 axis facilitated LUAD progression in a feedback way through CAF-tumor interaction in the TME. The gene discussed is CLCN3; the disease is neoplasm.